This brand name is authorized in Austria, Canada, France, Croatia, Ireland, Israel, Italy, Lithuania, Romania, United Kingdom, United States
The drug PLUVICTO contains one active pharmaceutical ingredient (API):
|
1
Lutetium ¹⁷⁷Lu vipivotide tetraxetan
UNII G6UF363ECX - LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
|
|
|
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| PLUVICTO Solution for injection/infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V10XX05 | V Various → V10 Therapeutic radiopharmaceuticals → V10X Other therapeutic radiopharmaceuticals → V10XX Various therapeutic radiopharmaceuticals | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: CA | Health Products and Food Branch | Identifier(s): 02530198 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 68234294 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 9237 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 050419011 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1096074 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W69480001 |
| Country: US | FDA, National Drug Code | Identifier(s): 69488-010 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
